GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Price-to-Free-Cash-Flow

ANG Lifesciences India (BOM:540694) Price-to-Free-Cash-Flow : N/A (As of Jun. 08, 2024)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India Price-to-Free-Cash-Flow?

As of today (2024-06-08), ANG Lifesciences India's share price is ₹51.72. ANG Lifesciences India's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00. Hence, ANG Lifesciences India's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for ANG Lifesciences India's Price-to-Free-Cash-Flow or its related term are showing as below:

BOM:540694' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 7.65   Max: 153.72
Current: 4.28

During the past 11 years, ANG Lifesciences India's highest Price-to-Free-Cash-Flow Ratio was 153.72. The lowest was 0.00. And the median was 7.65.

BOM:540694's Price-to-Free-Cash-Flow is ranked better than
94.69% of 527 companies
in the Drug Manufacturers industry
Industry Median: 22.85 vs BOM:540694: 4.28

ANG Lifesciences India's Free Cash Flow per Share for the three months ended in Dec. 2023 was ₹0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 70.80% per year.

During the past 11 years, ANG Lifesciences India's highest 3-Year average Free Cash Flow per Share Growth Rate was 129.60% per year. The lowest was -2.00% per year. And the median was 38.00% per year.


ANG Lifesciences India Price-to-Free-Cash-Flow Historical Data

The historical data trend for ANG Lifesciences India's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India Price-to-Free-Cash-Flow Chart

ANG Lifesciences India Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.76 4.91 9.08 - 6.20

ANG Lifesciences India Quarterly Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.20 - - -

Competitive Comparison of ANG Lifesciences India's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANG Lifesciences India's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's Price-to-Free-Cash-Flow falls into.



ANG Lifesciences India Price-to-Free-Cash-Flow Calculation

ANG Lifesciences India's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=51.72/0
=N/A

ANG Lifesciences India's Share Price of today is ₹51.72.
ANG Lifesciences India's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

ANG Lifesciences India  (BOM:540694) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


ANG Lifesciences India Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ANG Lifesciences India (BOM:540694) Business Description

Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.

ANG Lifesciences India (BOM:540694) Headlines

No Headlines